Ignite Creation Date:
2025-12-24 @ 10:32 PM
Ignite Modification Date:
2025-12-25 @ 8:05 PM
Study NCT ID:
NCT05323435
Status:
COMPLETED
Last Update Posted:
2023-04-25
First Post:
2022-04-11
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Immunogenicity and Safety Study of Recombinant Two-Component COVID-19 Vaccine (CHO Cell)(ReCOV)
Sponsor:
Jiangsu Rec-Biotechnology Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-05-30
Start Date Type:
ACTUAL
Primary Completion Date:
2022-07-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-16
Completion Date Type:
ACTUAL
First Submit Date:
2022-04-11
First Submit QC Date:
None
Study First Post Date:
2022-04-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-24
Last Update Post Date:
2023-04-25
Last Update Post Date Type:
ACTUAL